Faruqi and Faruqui, LLP Logo
Share this page

Iridex Corp. (IRIX)



Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Iridex Corp. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Iridex Corp. (“Iridex” or the “Company”) (NASDAQ:IRIX).

On February 23, 2018, the Company announced that it has issued a recall for TruFocus LIO Premiere, a head-mounted indirect ophthalmoscope used to view and perform laser treatments on patients’ eyes. Iridex stated that it has “received reports of three adverse events occurring during procedures in which the TruFocus LIO Premiere was used.”

On this news, Irix’s share price declined.

If you invested in Iridex stock or options and would like to discuss your legal rights, cplease fill out the form below.  There is no cost or obligation to you.You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. 

Contact Us

To contact Faruqi & Faruqi, LLP please call (877) 247-4292 or (212) 983-9330, or please
fill out the form below and a Firm representative will contact you.

  • Case:
    Iridex Corp. (IRIX)

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Case Details


  • 02/27/2018

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.